Intended Use

The AI-ECG Tracker is intended to be used by qualified healthcare professionals in hospitals and healthcare facilities for the assessment of arrhythmias using ECG data acquired from adults (age 22 and older) without pacemakers.

Technology

The device is a distributed ECG auto analysis system using AI (convolutional neural network) for beat classification of ECG waveform data uploaded by users. The AI model is locked post-development and does not self-learn. The software provides automated interpretation results and ECG measurements which can be reviewed and modified by physicians. It is developed in C# and C/C++ using Microsoft .Net framework and accessed through an API.

Performance

Bench testing demonstrated the device meets all design specifications and complies with IEC 60601-2-25, AAMI/ANSI EC57, IEC 60601-2-47, IEC 62304 software lifecycle, and ISO14971 risk management standards. Testing showed substantial equivalence to the predicate Monebo Automated ECG Analysis and Interpretation Software Library.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    1/8/2020

    2 months
  • 2

    FDA Approval

    3/20/2020

Other devices from Shenzhen Carewell Electronics Co., Ltd.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.